About Yposkesi
Yposkesi is a company based in Paris (France) founded in 2016 was acquired by SK in March 2021. Yposkesi offers products and services including Process Development, Viral Vector Manufacturing, Plasmid DNA Manufacturing, and Cell Therapy Manufacturing.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sk Pharmteco Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Yposkesi
Yposkesi offers a comprehensive portfolio of products and services, including Process Development, Viral Vector Manufacturing, Plasmid DNA Manufacturing, and Cell Therapy Manufacturing.
Efficient development for cell and gene therapy processes.
Scalable production of viral vectors for gene therapies.
Production of plasmid DNA for therapy development.
CGMP manufacturing for autologous and allogeneic therapies.
Funding Insights of Yposkesi
Detailed funding history for Yposkesi
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Yposkesi
Yposkesi has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SK.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on energy, chemical, semiconductor, logistics, and multiple sectors
|
Locked | Locked | Locked |
Investor details for Yposkesi
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Yposkesi
Investment portfolio details for Yposkesi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Yposkesi
Detailed financials for Yposkesi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Yposkesi Comparisons
Peer comparison for Yposkesi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Yposkesi
Detailed competitors of Yposkesi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Yposkesi
Complete news archive for Yposkesi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yposkesi
Yposkesi was founded in 2016.
Yposkesi is headquartered in Paris, France.
Alain Lamproye is the current CEO of Yposkesi.
Yposkesi was founded in 2016 in Paris, France, as a biotechnology firm focused on gene and cell therapy. Lentiviral and adenoviral vectors, along with CD34 cells for ex vivo applications, are produced. Contract manufacturing services are also provided to support related therapeutic developments in the sector. Operations emphasize advanced vector technologies for clinical and research needs.
Yposkesi offers Process Development, Viral Vector Manufacturing, Plasmid DNA Manufacturing, and Cell Therapy Manufacturing.
Yposkesi has 1 investor. Key investors include SK.